PMV
PMV Do and dare company
mute

PMV is a do and dare company that is shaping the future of the Flemish economy.

PMV provides finance for promising businesses, from their very start, through their various growth stages and even on to operating internationally.

Working with and for the government and other partners, PMV implements projects that are important for prosperity and wellbeing in Flanders.

PMV coordinates the investment funds of the European Fund for Strategic Investments (EFSI) in Flanders

PMV is the contact point for every enquire for the Juncker Plan, officially the "European Fund for Strategic Investments" (EFSI).

More info

News

28
/03

Oxypoint successfully raises €3.8 million in series A funding

Antwerp, March 28th, 2018 - Oxypoint nv, the award-winning University of Antwerp spin-off, bringing innovation to the medical device market for oxygen therapy in hospitals, announced today the closing of a €3.8 million Series A financing round led by the Flemish investment company PMV, together with a family office. The investment round was guided by Wouter Van Roost, who was appointed CEO of the company. The company will use the proceeds to bring its unique proprietary CE-labelled Econo-Comfort™ Oxygen Flowmeter to the European market and to further expand its product range of novel oxygen-therapy administering medical devices.

portfolio

Q-Biologicals

Q-Biologicals
Testimonial: 
Q-Biologicals is een Gents biopharmabedrijf dat een breed gamma diensten aanbiedt in procesontwikkeling en biomanufacturing.

Bubble Post

Bubble Post
Testimonial: 
De Gentse onderneming Bubble Post verzorgt met cargofietsen en elektrische voertuigen goederentransport van en naar het centrum vanuit een eigen depot aan de stadsrand.

Argen-X

Argen-X
Testimonial: 
Het biotechnologiebedrijf arGEN-X uit Zwijnaarde ontwikkelt biologische medicijnen voor de bestrijding van auto-immuunziektes en kanker op basis van antistoffen van lama’s.

Pharma Diagnostics

Pharma Diagnostics
Testimonial: 
PharmaDiagnostics werd opgericht in 2007. Op hun uniek technologieplatform SoPRano™ bieden zij dienstverlening aan levenswetenschappenonderzoekers.